Synopsis
Synopsis
0
JDMF
0
EU WC
0
KDMF
0
NDC API
0
VMF
0
Listed Suppliers
0
API
0
Europe
DRUG PRODUCT COMPOSITIONS
0
EDQM
0
USP
0
JP
0
Others
0
US Patents
0
US Exclusivities
0
Health Canada Patents
0
Data Compilation #PharmaFlow
0
Stock Recap #PipelineProspector
0
Weekly News Recap #Phispers
Annual Reports
NA
Finished Drug Prices
NA
1. Insulin Novo Monotard
2. Insulin, Lente
3. Insulin, Lente, Monocomponent
4. Insulin, Monotard
5. Lente Insulin
6. Monotard Insulin
7. Monotard, Insulin Novo
8. Novo Monotard, Insulin
1. 8049-62-5
2. Insulin Zinc Suspension
3. Caninsulin
4. Monotard
5. Insulin Lente
6. Lente Insulin
7. Zinc-insulinum
8. Insulin Zinc
9. Insulin, Lente
10. Insulin Semilente
11. Novolin U
12. Nph Insulin
13. Semilente Insulin
14. Insulin Nph
15. Insulin Lente Mc
16. Ultralente Insulin
17. Nph Iletin
18. Insulin Novo Lente
19. Insulin, Ultralente
20. Ultra Lente Iszilin
21. Insulin Zinc Complex
22. Insulin, Crystalline
23. Insulin, Semi-lente
24. Izsab
25. Iletin U 40
26. Zinc Insulin
27. Suspensio Zinc-insulini
28. Ultralenta Zinc Insulin
29. Insulin, Crystalline Zinc
30. Insulini Zinci Suspensio Mixta
31. Prompt Insulin Zinc Suspension
32. Lente Iletin
33. Insulin Isophane
34. Extended Zinc Insulin Suspension
35. Insulini Zinci Amorphi Suspensio
36. Iniectabile Insulini Zinci Amorphi
37. Insulin Human Zinc
38. Insulini Zinco Amorphi Aquosuspensa
39. Einecs 232-469-4
40. Iniectabile Insulini Zinci Compositum
41. Injectio Insulini Cum Zinco Neutralis
42. Insulini Zinci Cristallisati Suspensio
43. Iniectabile Insulini Zinci Cristallisati
44. Insulini Zinco Cristallisati Aquosuspensa
45. Insulin, Isophane
46. Insulina-zinco Sospensione Composta [dcit]
47. Suspension Injectable D'insuline Zinc Mixte
48. Insulina-zinco Sospensione (amorfa) [dcit]
49. Suspension Injectable D'insuline Zinc Amorphe
50. Insulin Zinc [usp:ban]
51. Insulin Human Zinc [usp]
52. Insulini Cum Zinco (crystallisati) [inn-latin]
53. Insulina-zinco Sospensione (crisstallina) [dcit]
54. Suspension Injectable D'insuline Zinc Cristallisee
55. Suspension D'insuline Zinc (amorphe) [inn-french]
56. Insulini Cum Zinco (amorphi) Suspensio [inn-latin]
57. Suspension D'insuline Zinc (composee) [inn-french]
58. Suspension De Insulina Cinc (amorfa) [inn-spanish]
59. Suspension De Insulina Cinc (compuesta) [inn-spanish]
60. Suspension De Insulina Cinc (cristal.) [inn-spanish]
61. Suspension D'insuline Zinc (cristallisee) [inn-french]
62. Insulini Cum Zinco Suspensio Compositacompound [inn-latin]
63. Insulina-zinco Sospensione Composta
64. Insulini Cum Zinco (crystallisati)
65. Insulina-zinco Sospensione (amorfa)
66. Suspension D'insuline Zinc (amorphe)
67. Suspension De Insulina Cinc (amorfa)
68. Suspension D'insuline Zinc (composee)
69. Insulini Cum Zinco (amorphi) Suspensio
70. Suspension De Insulina Cinc (cristal.)
71. Suspension De Insulina Cinc (compuesta)
72. Insulin Zinc Suspension, Compound
73. Insulin Zinc Suspension, Compound [inn]
74. Insulina-zinco Sospensione (crisstallina)
75. Nph
76. Suspension D'insuline Zinc (cristallisee)
77. Insulini Cum Zinco Suspensio Compositacompound
78. Insulin Zinc Injection (aqueous Suspension)
79. Insulin Zinc Injection (aqueous Suspension) [jan]
80. Insulin Zinc Purified Porcine (suspension)
81. Insulin Zinc Purified Porcine (suspension) [jan]
Molecular Weight | 5873 g/mol |
---|---|
Molecular Formula | C257H383N65O77S6Zn |
Hydrogen Bond Donor Count | 76 |
Hydrogen Bond Acceptor Count | 89 |
Rotatable Bond Count | 179 |
Exact Mass | 5869.573502 g/mol |
Monoisotopic Mass | 5867.566792 g/mol |
Topological Polar Surface Area | 2440 Ų |
Heavy Atom Count | 406 |
Formal Charge | 0 |
Complexity | 14800 |
Isotope Atom Count | 0 |
Defined Atom Stereocenter Count | 51 |
Undefined Atom Stereocenter Count | 3 |
Defined Bond Stereocenter Count | 0 |
Undefined Bond Stereocenter Count | 0 |
Covalently Bonded Unit Count | 2 |
Hypoglycemic Agents
Substances which lower blood glucose levels. (See all compounds classified as Hypoglycemic Agents.)
Global Sales Information
Market Place
ABOUT THIS PAGE
A Caninsulin manufacturer is defined as any person or entity involved in the manufacture, preparation, processing, compounding or propagation of Caninsulin, including repackagers and relabelers. The FDA regulates Caninsulin manufacturers to ensure that their products comply with relevant laws and regulations and are safe and effective to use. Caninsulin API Manufacturers are required to adhere to Good Manufacturing Practices (GMP) to ensure that their products are consistently manufactured to meet established quality criteria.
A Caninsulin supplier is an individual or a company that provides Caninsulin active pharmaceutical ingredient (API) or Caninsulin finished formulations upon request. The Caninsulin suppliers may include Caninsulin API manufacturers, exporters, distributors and traders.
click here to find a list of Caninsulin suppliers with USDMF, JDMF, KDMF, CEP, GMP, COA and API Price related information on PharmaCompass.
A Caninsulin DMF (Drug Master File) is a document detailing the whole manufacturing process of Caninsulin active pharmaceutical ingredient (API) in detail. Different forms of Caninsulin DMFs exist exist since differing nations have different regulations, such as Caninsulin USDMF, ASMF (EDMF), JDMF, CDMF, etc.
A Caninsulin DMF submitted to regulatory agencies in the US is known as a USDMF. Caninsulin USDMF includes data on Caninsulin's chemical properties, information on the facilities and procedures used, and details about packaging and storage. The Caninsulin USDMF is kept confidential to protect the manufacturer’s intellectual property.
click here to find a list of Caninsulin suppliers with USDMF on PharmaCompass.
A Caninsulin CEP of the European Pharmacopoeia monograph is often referred to as a Caninsulin Certificate of Suitability (COS). The purpose of a Caninsulin CEP is to show that the European Pharmacopoeia monograph adequately controls the purity of Caninsulin EP produced by a given manufacturer. Suppliers of raw materials can prove the suitability of Caninsulin to their clients by showing that a Caninsulin CEP has been issued for it. The manufacturer submits a Caninsulin CEP (COS) as part of the market authorization procedure, and it takes on the role of a Caninsulin CEP holder for the record. Additionally, the data presented in the Caninsulin CEP (COS) is managed confidentially and offers a centralized system acknowledged by numerous nations, exactly like the Caninsulin DMF.
A Caninsulin CEP (COS) is recognised by all 36 nations that make up the European Pharmacopoeia Convention. Caninsulin CEPs may be accepted in nations that are not members of the Ph. Eur. at the discretion of the authorities there.
click here to find a list of Caninsulin suppliers with CEP (COS) on PharmaCompass.
Caninsulin Active pharmaceutical ingredient (API) is produced in GMP-certified manufacturing facility.
GMP stands for Good Manufacturing Practices, which is a system used in the pharmaceutical industry to make sure that goods are regularly produced and monitored in accordance with quality standards. The FDA’s current Good Manufacturing Practices requirements are referred to as cGMP or current GMP which indicates that the company follows the most recent GMP specifications. The World Health Organization (WHO) has its own set of GMP guidelines, called the WHO GMP. Different countries can also set their own guidelines for GMP like China (Chinese GMP) or the EU (EU GMP).
PharmaCompass offers a list of Caninsulin GMP manufacturers, exporters & distributors, which can be sorted by USDMF, JDMF, KDMF, CEP (COS), WC, API price, and more, enabling you to easily find the right Caninsulin GMP manufacturer or Caninsulin GMP API supplier for your needs.
A Caninsulin CoA (Certificate of Analysis) is a formal document that attests to Caninsulin's compliance with Caninsulin specifications and serves as a tool for batch-level quality control.
Caninsulin CoA mostly includes findings from lab analyses of a specific batch. For each Caninsulin CoA document that a company creates, the USFDA specifies specific requirements, such as supplier information, material identification, transportation data, evidence of conformity and signature data.
Caninsulin may be tested according to a variety of international standards, such as European Pharmacopoeia (Caninsulin EP), Caninsulin JP (Japanese Pharmacopeia) and the US Pharmacopoeia (Caninsulin USP).
LOOKING FOR A SUPPLIER?